Document is current
Any future updates will be listed below
-
Authors
Cameroni, Elisabetta
Bowen, John E. https://orcid.org/0000-0003-3590-9727
Rosen, Laura E. https://orcid.org/0000-0002-8030-0219
Saliba, Christian
Zepeda, Samantha K. https://orcid.org/0000-0003-0005-9793
Culap, Katja https://orcid.org/0000-0002-0956-0018
Pinto, Dora
VanBlargan, Laura A. https://orcid.org/0000-0002-8922-8946
De Marco, Anna
di Iulio, Julia
Zatta, Fabrizia
Kaiser, Hannah https://orcid.org/0000-0002-3991-7401
Noack, Julia
Farhat, Nisar
Czudnochowski, Nadine
Havenar-Daughton, Colin https://orcid.org/0000-0002-2880-3927
Sprouse, Kaitlin R. https://orcid.org/0000-0003-0007-2226
Dillen, Josh R.
Powell, Abigail E.
Chen, Alex https://orcid.org/0000-0003-2620-5066
Maher, Cyrus https://orcid.org/0000-0002-6666-3574
Yin, Li https://orcid.org/0000-0003-2634-9158
Sun, David
Soriaga, Leah https://orcid.org/0000-0001-5852-741X
Bassi, Jessica
Silacci-Fregni, Chiara
Gustafsson, Claes
Franko, Nicholas M. https://orcid.org/0000-0001-8165-6332
Logue, Jenni https://orcid.org/0000-0002-7889-8960
Iqbal, Najeeha Talat
Mazzitelli, Ignacio
Geffner, Jorge
Grifantini, Renata
Chu, Helen
Gori, Andrea
Riva, Agostino https://orcid.org/0000-0003-3171-3049
Giannini, Olivier
Ceschi, Alessandro https://orcid.org/0000-0002-4308-0405
Ferrari, Paolo https://orcid.org/0000-0002-9619-3104
Cippà, Pietro E.
Franzetti-Pellanda, Alessandra
Garzoni, Christian
Halfmann, Peter J. https://orcid.org/0000-0002-1648-1625
Kawaoka, Yoshihiro https://orcid.org/0000-0001-5061-8296
Hebner, Christy
Purcell, Lisa A.
Piccoli, Luca https://orcid.org/0000-0002-1085-6502
Pizzuto, Matteo Samuele https://orcid.org/0000-0001-5776-654X
Walls, Alexandra C. https://orcid.org/0000-0002-9636-8330
Diamond, Michael S. https://orcid.org/0000-0002-8791-3165
Telenti, Amalio https://orcid.org/0000-0001-6290-7677
Virgin, Herbert W. https://orcid.org/0000-0001-8580-7628
Lanzavecchia, Antonio
Snell, Gyorgy https://orcid.org/0000-0003-1475-659X
Veesler, David https://orcid.org/0000-0002-6019-8675
Corti, Davide https://orcid.org/0000-0002-5797-1364
- License Information
-
More Information
Article History
Received: 12 December 2021
Accepted: 23 December 2021
First Online: 23 December 2021
Competing interests
: E.C., K.C., C.S., D.P., F.Z., A.D.M., A.L., L.P., M.S.P., D.C., H.K., J.N., N.F., J.d.I., L.E.R., N.C., C.H.-D., K.R.S., J.R.D., A.E.P., A.C., C.M., L.Y., D.S., L.S., L.A.P., C.H., A.T., H.W.V. and G.S. are employees of Vir Biotechnology and may hold shares in Vir Biotechnology. L.A.P. is a former employee and shareholder in Regeneron Pharmaceuticals. Regeneron provided no funding for this work. H.W.V. is a founder and holds shares in PierianDx and Casma Therapeutics. Neither company provided resources. The D.V. laboratory has received a sponsored research agreement from Vir Biotechnology. H.C. reported consulting with Ellume, Pfizer, the Bill and Melinda Gates Foundation, Glaxo Smith Kline and Merck. She has received research funding from Emergent Ventures, Gates Ventures, Sanofi Pasteur and the Bill and Melinda Gates Foundation, and support and reagents from Ellume and Cepheid outside of the submitted work. M.S.D. is a consultant for Inbios, Vir Biotechnology, Senda Biosciences and Carnival Corporation, and is on the Scientific Advisory Boards of Moderna and Immunome. The M.S.D. laboratory has received funding support in sponsored research agreements from Moderna, Vir Biotechnology and Emergent BioSolutions. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Free to read: This content has been made available to all.
